TABLE 2

Patient-Based Analysis

Imaging modality (performed on n patients)No. of patients with positive lesionsMean no. of lesions per patient (range)
CT or MRI (n = 18)74.7 (0–18)
DMSA-V (n = 18)51.1 (0–13)
18F-FDG PET (n = 17)41.6 (0–18)
18F-DOPA PET (21)134.6 (0–21)
  • On the basis of the inclusion criteria, all patients were considered positive for tumor. Sensitivities for patient-based analysis were calculated using total number of patients scanned per imaging modality as reference.